Chan See Ching, Fan Sheung Tat
Department of Surgery, The University of Hong Kong, Queen Mary Hospital, 102 Pokfulam Road, Hong Kong, China.
World J Gastroenterol. 2008 Jan 7;14(1):15-21. doi: 10.3748/wjg.14.15.
Living donor liver transplantation (LDLT) has gone through its formative years and established as a legitimate treatment when a deceased donor liver graft is not timely or simply not available at all. Nevertheless, LDLT is characterized by its technical complexity and ethical controversy. These are the consequences of a single organ having to serve two subjects, the donor and the recipient, instantaneously. The transplant community has a common ground on assuring donor safety while achieving predictable recipient success. With this background, a reflection of the development of LDLT may be appropriate to direct future research and patient-care efforts on this life-saving treatment alternative.
活体肝移植（LDLT）已经历了其形成阶段，并在死者供肝不可及时或根本无法获得时成为一种合法的治疗方法。然而，LDLT具有技术复杂性和伦理争议的特点。这些是由于一个单一器官必须同时为两个个体，即供体和受体服务所导致的结果。移植界在确保供体安全的同时实现可预测的受体成功方面有共同的立场。在此背景下，对LDLT的发展进行反思可能有助于指导未来针对这种挽救生命的治疗选择的研究和患者护理工作。
